{
  "retracted": false,
  "timestamp": 1561939200000,
  "updates": [
    {
      "timestamp": 1562019028023,
      "identifier": {
        "doi": "10.1158/0008-5472.can-19-1515"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1158/0008-5472.can-14-1670"
  },
  "journal": "Cancer Research",
  "publisher": "American Association for Cancer Research (AACR)",
  "title": "Correction: Four-in-One Antibodies Have Superior Cancer Inhibitory Activity against EGFR, HER2, HER3, and VEGF through Disruption of HER/MET Crosstalk"
}
